SVRA Savara4.65-0.07 (-1.5%)
SVRA Savara4.96-0.04 (-0.8%)
SVRA Savara5.49-0.03 (-0.5%)
After Hours Gainer
SVRA Savara5.53-0.19-3.3%
After Hours:5.75+0.22 (+4.0%)
Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
Business WireFri, 20-Feb 4:15 PM
SVRA Savara4.68+0.51 (+12.2%)